1. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Issue 10084 (27th May 2017) Authors: Fellström, Bengt C; Barratt, Jonathan; Cook, Heather; Coppo, Rosanna; Feehally, John; de Fijter, Johan W; Floege, Jürgen; Hetzel, Gerd; Jardine, Alan G; Locatelli, Francesco; Maes, Bart D; Mercer, Alex; Ortiz, Fernanda; Praga, Manuel; Sørensen, Søren S; Tesar, Vladimir; Del Vecchio, Lucia Journal: Lancet Issue: Volume 389:Issue 10084(2017) Page Start: 2117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗